Registry for Apomorphine-, L-Dopa-Infusiontherapy and Deep Brain Stimulation in Patients with Parkinson’s Disease
Recruiting
- Conditions
- G20.00
- Registration Number
- DRKS00006735
- Lead Sponsor
- Department of NeurologyUniversity Hospital Cologne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Patients with PD, diagnosed according to British Brain Bank criteria which are eligible for treatment with Apomorphine and intra-jejunal l-dopa infusion therapy and deep brain stimulation.
Exclusion Criteria
- Clinically significant irregularities in the MRI scan like, e.g., strokes, cerebellar atrophy, and tumors.
- Clinically significant psychiatric diseases.
- Clinicallly significant neuropsychological impairments.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method on-motor (Non-motor Symptom Scale) and quality of life (Parkinson's Disease Questionnaire)
- Secondary Outcome Measures
Name Time Method Demographic data, treatment application data and hardware and procedure associated side effects, motor and non-motor symptoms